Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.94 Million SEK | 276.44% |
| 2022 | 781 Thousand SEK | -30.58% |
| 2021 | 1.12 Million SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.81 Million SEK | -1.09% |
| 2024 Q1 | 2.84 Million SEK | -3.2% |
| 2023 Q3 | 3.03 Million SEK | 410.61% |
| 2023 FY | 2.94 Million SEK | 276.44% |
| 2023 Q1 | 781 Thousand SEK | 0.0% |
| 2023 Q2 | 594 Thousand SEK | -23.94% |
| 2023 Q4 | 2.94 Million SEK | -3.07% |
| 2022 Q3 | 1.12 Million SEK | 0.0% |
| 2022 Q4 | 781 Thousand SEK | -30.58% |
| 2022 FY | 781 Thousand SEK | -30.58% |
| 2022 Q2 | 1.12 Million SEK | 0.0% |
| 2022 Q1 | 1.12 Million SEK | 0.0% |
| 2021 Q1 | 1 Million SEK | 0.0% |
| 2021 FY | 1.12 Million SEK | 0.0% |
| 2021 Q2 | 1.5 Million SEK | 50.0% |
| 2021 Q4 | 1.12 Million SEK | -10.0% |
| 2021 Q3 | 1.25 Million SEK | -16.67% |
| 2020 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 99.798% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 99.798% |
| Arcoma AB | 1.92 Million SEK | -52.569% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | 93.051% |
| BICO Group AB (publ) | 1.75 Billion SEK | 99.833% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | 94.905% |
| CellaVision AB (publ) | 28.66 Million SEK | 89.743% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -1218.386% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -67.712% |
| Dignitana AB (publ) | 6.07 Million SEK | 51.621% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -27.826% |
| Getinge AB (publ) | 3.9 Billion SEK | 99.925% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | 53.722% |
| Iconovo AB (publ) | 4.9 Million SEK | 40.084% |
| Integrum AB (publ) | 4.84 Million SEK | 39.313% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -1327.018% |
| Mentice AB (publ) | 2.14 Million SEK | -37.127% |
| OssDsign AB (publ) | 214 Thousand SEK | -1273.832% |
| Paxman AB (publ) | 2.53 Million SEK | -16.114% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | 2.13% |
| SciBase Holding AB (publ) | 4.17 Million SEK | 29.648% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | 84.691% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -190.514% |
| Senzime AB (publ) | 8.57 Million SEK | 65.726% |
| SpectraCure AB (publ) | 4.39 Million SEK | 33.136% |
| Stille AB | 38.06 Million SEK | 92.277% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 99.843% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | 86.112% |